Lein M - Search Results

1

Germ cell tumors of the gonads: a selective review emphasizing problems in drug resistance and current therapy options.

Schrader M, Kempkensteffen C, Christoph F, Hinz S, Weikert S, Lein M, Krause H, Stephan C, Jung K, Hoepfner M, Albers P, Miller K, Schostak M. Schrader M, et al. Among authors: lein m. Oncology. 2009;76(2):77-84. doi: 10.1159/000187426. Epub 2008 Dec 20. Oncology. 2009. PMID: 19122465 Review.

2

Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.

Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Loening SA, Jung K. Ramankulov A, et al. Among authors: lein m. Cancer Lett. 2008 Sep 28;269(1):85-92. doi: 10.1016/j.canlet.2008.04.022. Epub 2008 May 27. Cancer Lett. 2008. PMID: 18504068

3

MicroRNAs and cancer: current state and future perspectives in urologic oncology.

Schaefer A, Jung M, Kristiansen G, Lein M, Schrader M, Miller K, Stephan C, Jung K. Schaefer A, et al. Among authors: lein m. Urol Oncol. 2010 Jan-Feb;28(1):4-13. doi: 10.1016/j.urolonc.2008.10.021. Epub 2008 Dec 30. Urol Oncol. 2010. PMID: 19117772 Review.

4

Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.

Abramjuk C, Bueschges M, Schnorr J, Jung K, Staack A, Lein M. Abramjuk C, et al. Among authors: lein m. Oncol Rep. 2009 Aug;22(2):409-14. Oncol Rep. 2009. PMID: 19578784

5

Soluble CD44 variants in the serum of patients with urological malignancies.

Lein M, Jung K, Weiss S, Schnorr D, Loening SA. Lein M, et al. Oncology. 1997 May-Jun;54(3):226-30. doi: 10.1159/000227693. Oncology. 1997. PMID: 9143404

6

[Adjuvant and neoadjuvant drug therapy for prostate cancer].

Miller K, Lein M, Schostak M, Schrader M. Miller K, et al. Among authors: lein m. Urologe A. 2008 Nov;47(11):1460-4. doi: 10.1007/s00120-008-1728-z. Urologe A. 2008. PMID: 18813902 Review. German.

7

[Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options].

Ebbing J, Christoph F, Kempkensteffen C, Weikert S, Schostak M, Hinz S, Lein M, Miller K, Schrader M. Ebbing J, et al. Among authors: lein m. Aktuelle Urol. 2008 Nov;39(6):429-35. doi: 10.1055/s-2008-1038284. Epub 2008 Oct 31. Aktuelle Urol. 2008. PMID: 18979397 Review. German.

8

Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.

Ramankulov A, Lein M, Kristiansen G, Meyer HA, Loening SA, Jung K. Ramankulov A, et al. Among authors: lein m. J Cancer Res Clin Oncol. 2007 Sep;133(9):643-52. doi: 10.1007/s00432-007-0215-z. Epub 2007 May 4. J Cancer Res Clin Oncol. 2007. PMID: 17479289

9

PSA and other tissue kallikreins for prostate cancer detection.

Stephan C, Jung K, Lein M, Diamandis EP. Stephan C, et al. Among authors: lein m. Eur J Cancer. 2007 Sep;43(13):1918-26. doi: 10.1016/j.ejca.2007.06.006. Epub 2007 Aug 3. Eur J Cancer. 2007. PMID: 17689069 Review.

10

Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.

Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Jung K. Ramankulov A, et al. Among authors: lein m. Cancer Sci. 2008 Jun;99(6):1188-94. doi: 10.1111/j.1349-7006.2008.00802.x. Epub 2008 Apr 14. Cancer Sci. 2008. PMID: 18422740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters